zurück

Glycopyrronium (known active substance with new document protection (§16): severe primary axillary hyperhidrosis)

 

Subject:

  • Active Sustance: Glycopyrronium
  • Name: Axhidrox®
  • Therapeutic area: Axillary hyperhidrosis
  • Pharmaceutical company: Dr. August Wolff GmbH & Co. KG Arzneimittel

 

Time table:

  • Start: 01.08.2022
  • Final decision by G-BA: 19.01.2023

 

Final decision:

  • No additional benefit proved